OpenWorld, Inc. filed a Form 8-K on November 4, 2026, disclosing that stockholders acting by written consent on November 3, 2026, approved the issuance of up to 5,035,970 shares of common stock upon the exercise of Series A and Series B Common Stock purchase warrants.
Key Highlights
- Majority consent reached: Stockholders holding approximately 50.27% of issued and outstanding common stock approved the Share Issuance Proposal by written consent on November 3, 2026.
- Total warrant shares: Up to 5,035,970 shares of common stock may be issued upon exercise of the Common Warrants in aggregate.
- Two warrant series: Series A Common Warrants cover up to 2,517,985 shares and Series B Common Warrants cover up to 2,517,985 shares, according to the filing.
- Warrants issued October 30, 2026: The Common Warrants were issued to an institutional investor in a registered direct offering pursuant to a securities purchase agreement dated October 29, 2026.
- Exercisability condition: The Common Warrants will not become exercisable until the twentieth day after the definitive Information Statement on Schedule 14C is provided to stockholders of record.
- Preliminary 14C filed: The company filed a preliminary Information Statement on Schedule 14C with the SEC on November 4, 2026, to inform stockholders of the action taken.
- Nasdaq compliance: The approval was described as required by the Purchase Agreement and for the purposes of Nasdaq Listing Rule 5635(d).
OpenWorld Stockholder Written Consent on Warrant Share Issuance
According to the Form 8-K filed by OpenWorld, Inc. (NASDAQ:OPNW) on November 4, 2026, the company disclosed that consenting stockholders holding approximately 50.27% of its issued and outstanding shares of common stock, par value $0.001 per share, acting by written consent under Section 78.320 of the Nevada Revised Statutes, approved the Share Issuance Proposal on November 3, 2026. That proposal authorizes the issuance of up to an aggregate of 5,035,970 shares of common stock upon exercise of two series of warrants.
The filing states that the Common Warrants consist of Series A Common Stock purchase warrants to purchase up to 2,517,985 shares and Series B Common Stock purchase warrants to purchase up to 2,517,985 shares. The warrants were issued to an institutional investor on October 30, 2026, in a registered direct offering under a securities purchase agreement dated October 29, 2026, as previously reported in the company's Current Report on Form 8-K filed October 30, 2026 (Film no. 261508956).
The filing further states that the Common Warrants will not become exercisable pursuant to their terms until the twentieth day after the definitive Information Statement on Schedule 14C relating to the Share Issuance Approval is provided to the company's stockholders of record. The company disclosed that it filed a preliminary Information Statement on Schedule 14C with the SEC on November 4, 2026, to notify stockholders of the written consent action. The Form 8-K was signed by Gerard Hernandez, Chief Financial Officer of OpenWorld, Inc.
What Was Disclosed
OpenWorld, Inc. reported that stockholders representing approximately 50.27% of outstanding voting power approved, by written consent, the issuance of up to 5,035,970 warrant shares tied to warrants issued in an October 2026 registered direct offering, subject to a 20-day waiting period after the definitive Schedule 14C is distributed.



Please wait processing your request...